Icahn School of Medicine at Mount Sinai
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Icahn School of Medicine at Mount Sinai sits in the top decile of US sponsors by registered trial count (#48 of 15,742 sponsors by registered trial count).
Icahn School of Medicine at Mount Sinai: 708 sponsored US clinical trials, 163 recruiting.
Icahn School of Medicine at Mount Sinai sponsors 708 registered US clinical trials on ClinicalTrials.gov, 163 of them currently recruiting, and 423 completed. 88 of these trials are in Phase 3-4 (later-stage) and 138 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 7 trials.
Top-decile sponsor footprint
Icahn School of Medicine at Mount Sinai ranks in the top decile of sponsors by registered trial count (#48 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
423 of 499 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
708 total, page 13 of 15
Effect of a Low Advanced Glycation End Products (AGE) Diet in the Metabolic Syndrome
NCT01363141
Effect of Whole Grain Diet on Insulin Sensitivity, Advanced Glycation End Products and Inflammatory Markers in Pre-diabetes
NCT01248286
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
NCT01358097
Informing Decisions in Chronic Critical Illness: A Randomized Control Trial (RCT)
NCT01230099
Regional Anesthesia for Sickle Cell Crisis Using Ultrasound in The Emergency Department: Phase I
NCT01256281
Medication Adherence in Children Who Had a Liver Transplant
NCT01154075
Equity in Diagnostic Imaging Trial
NCT01611714
Preterm Premature Rupture of Membranes (PPROM): Bed Rest Versus Activity Trial
NCT01544387
Cognitive Training for Depression
NCT01936506
High Flow Nasal Cannula Versus Bubble Nasal CPAP for the Treatment of Transient Tachypnea of the Newborn in Infants ≥ 35 Weeks Gestation
NCT01270581
Use of AEEG as Predictor of Long-term Motor Outcome in Neonates With Congenital Heart Disease
NCT01291797
Effects of Live Music on the Perception of Noise in the SICU: A Patient, Caregiver, and Medical Staff Environmental Study
NCT02269527
Hybrid Revascularization Observational Study
NCT01121263
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
NCT01190904
Management Practices and the Risk of Infection Following Cardiac Surgery
NCT01089712
Prolonging Remission in Depressed Elderly (PRIDE)
NCT01028508
L-Tyrosine Supplementation in Patients With Fibromyalgia
NCT01219049
Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia Areata
NCT01385839
Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat
NCT01971203
Neural and Behavioral Outcomes of Social Skills Groups in Children With Autism Spectrum Disorder (ASD)
NCT01190917
Role of Absolute Cerebral Oximetry to Prevent Neurocognitive Injury in Elderly Patients Undergoing Cardiac Surgery
NCT00991328
Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD
NCT00927784
Using a Preparation and Education Intervention to Reduce Postpartum Depression Among New Mothers (The MADE IT 2 Study)
NCT00951717
Treatment Study of Bipolar Depression
NCT00947791
Fuel Utilization, Diet Composition, and Exercise in African American Women
NCT04293367
Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium
NCT01321892
Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy
NCT00967629
Bilateral Bispectral Index (BIS) Study
NCT01187420
Prevent Return of Stroke Study
NCT01027273
Genetic Response to Warfarin in Healthy Subjects
NCT01520402
Evaluation of the Mobile Acute Care of the Elderly (MACE) Unit
NCT00927160
Patterns of Non-Adherence to Dual Anti-Platelet Regimen In Stented Patients
NCT00998127
Training Community Members to Deliver HIV Prevention Programs to Urban Youth
NCT00859144
Effectiveness Study of Community-Based, Peer-Led Education on Weight Loss and Diabetes
NCT01004848
Ammonium Lactate Lotion 12% (Lac-hydrin®) and Halobetasol Propionate Ointment 0.05% (Ultravate®) in the Treatment and Maintenance of Psoriasis
NCT01111123
A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6
NCT00900744
Comparing the Effectiveness of Repairing Versus Replacing the Heart's Mitral Valve in People With Severe Chronic Ischemic Mitral Regurgitation
NCT00807040
Comparing the Effectiveness of a Mitral Valve Repair Procedure in Combination With Coronary Artery Bypass Grafting (CABG) Versus CABG Alone in People With Moderate Ischemic Mitral Regurgitation
NCT00806988
Improving Pain and Function in Hip Fracture
NCT00749489
Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP)
NCT00953771
Parent-Based Treatment for Pediatric Overweight
NCT00807560
Efficacy and Safety of Galantamine for Improving Dysfunction in People With Bipolar Disorder
NCT00741598
CBT as an Adjunct to SRIs in the Treatment of BDD
NCT00211809
Effectiveness of Chinese Herbal Therapy for Asthma
NCT00712296
Cysteamine Therapy for Major Depressive Disorder
NCT00715559
Fluid Management in Transient Tachypnea of the Newborn
NCT01225029
Familial Myeloproliferative Disorders
NCT00666289
Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients
NCT00655226
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
NCT00561678
Improving Executive Functioning After Traumatic Brain Injury (TBI): A Trial of the "Short Term Executive Plus" Program
NCT00627237
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 57 |
| Phase 2 | 81 |
| Phase 3 | 21 |
| Phase 4 | 67 |
Therapeutic Areas
What is open in the Icahn School of Medicine at Mount Sinai pipeline
163 recruiting of 708 indexed (23% open); 423 completed (60%).
Phase mix: 88 late (III/IV) vs 138 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Icahn School of Medicine at Mount Sinai: open-pipeline peers nationwide
Peers matched on 708 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
Icahn School of Medicine at Mount Sinai sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 708 trials (± recruiting share)
- Sanofi · 713 trials · 10% recruiting
- Weill Medical College of Cornell University · 701 trials · 18% recruiting
- University of Miami · 721 trials · 20% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Clemson University · 23% recruiting · 13 trials
- Liberating Technologies · 23% recruiting · 13 trials
- Rahul Aggarwal · 23% recruiting · 13 trials
- Sequenom · 23% recruiting · 26 trials
Related
What to do with this Icahn School of Medicine at Mount Sinai page
708 registered trials is a research-attention snapshot, not an endorsement of Icahn School of Medicine at Mount Sinai or any single study.
- 163 of Icahn School of Medicine at Mount Sinai's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Icahn School of Medicine at Mount Sinai studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Icahn School of Medicine at Mount Sinai pipeline card: 708 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.